Quantcast

journal of neuroscience

Some Alzheimer patients show unique compensatory brain activity

A group of Canadian researchers has found the most direct evidence to date that people with early-stage Alzheimer Disease can engage additional areas in the brain to perform successfully on memory tests. Alzheimer’s is a progressive, degenerative disease that affects an individual’s ability to think, remember, understand and make decisions. People with early-stage Alzheimer’s begin to experience problems with their episodic and semantic memory. Semantic refers to the accumulation of general world knowledge gained over a lifetime (for example, names of countries, famous people, major historical events). Episodic refers to events that one experiences throughout his/her life (for example, having visited the dentist yesterday, or graduating from college back in 1950).

Pediatric Anesthesia Causes Brain Damage in Infant Rats

A team of researchers has found that drugs commonly used to anesthetize children can cause brain damage and long-term learning and memory disturbances in infant rats. The researchers report their findings in the Feb. 1 issue of the Journal of Neuroscience. “We frequently perform surgical procedures on children, including premature infants, and those procedures have become increasingly more complex and take longer to perform,” says the study’s lead author Vesna Jevtovic-Todorovic, M.D., associate professor of anesthesiology at the University of Virginia Health System. “That means many pediatric patients are being exposed to anesthetic drugs more frequently and for longer periods of time. Our results would suggest that might be problematic.”

Interleukin-6 May Lead to Drugs That Prevent Brain Injury From Diseases, Aging

A Mayo Clinic investigation of Interleukin-6, a hormone inside cells often considered a “bad actor” of the immune system because of its association with inflammation injuries and malignant diseases, shows that it also plays a therapeutic role in mice: it protects brain cells. Interleukin-6 — called IL-6 for short by researchers — may, in fact, be a “white knight” for mouse brain cells, or neurons, as brain cells also are called. These results, while early, may be promising for humans as well. The Mayo Clinic investigation is described in the Jan. 15 Journal of Neuroscience.